Evidence map›Paper›PMID 32582158›Full record

ArticleFrontiers in immunology2020

Prophylactic Activity of Orally Administered FliD-Reactive Monoclonal SIgA Against

Lisa Perruzza, Stefano Jaconi, Gloria Lombardo, Debora Pinna, Francesco Strati, Diego Morone, Frauke Seehusen, Yue Hu, Sakshi Bajoria, Jian Xiong and 8 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Immunoglobulin A protease fromGut microbes · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Recombinant Human Secretory IgA InducesACS infectious diseases · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

Lisa PerruzzaFaculty of Biomedical Sciences, Institute for Research in Biomedicine, Università della Svizzera Italiana (USI), Bellinzona, Switzerland.
Stefano JaconiHumabs BioMed SA a Subsidiary of Vir Biotechnology Inc., Bellinzona, Switzerland.
Gloria LombardoHumabs BioMed SA a Subsidiary of Vir Biotechnology Inc., Bellinzona, Switzerland.
Debora PinnaHumabs BioMed SA a Subsidiary of Vir Biotechnology Inc., Bellinzona, Switzerland.
Francesco StratiFaculty of Biomedical Sciences, Institute for Research in Biomedicine, Università della Svizzera Italiana (USI), Bellinzona, Switzerland.
Diego MoroneFaculty of Biomedical Sciences, Institute for Research in Biomedicine, Università della Svizzera Italiana (USI), Bellinzona, Switzerland.
Frauke SeehusenLaboratory for Animal Model Pathology (LAMP), Institute of Veterinary Pathology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
Yue HuDepartment of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, United States.
Sakshi BajoriaDepartment of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, United States.
Jian XiongDepartment of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, United States.
Ozan Selahattin KumruDepartment of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, United States.
Sangeeta Bagai JoshiDepartment of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, United States.
David Bernard VolkinDepartment of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, United States.
Renato PiantanidaDepartment of Otolaryngology-Head and Neck Surgery, Ospedale Regionale di Lugano, Lugano, Switzerland.
Fabio BenigniHumabs BioMed SA a Subsidiary of Vir Biotechnology Inc., Bellinzona, Switzerland.
Fabio GrassiFaculty of Biomedical Sciences, Institute for Research in Biomedicine, Università della Svizzera Italiana (USI), Bellinzona, Switzerland.
Davide CortiHumabs BioMed SA a Subsidiary of Vir Biotechnology Inc., Bellinzona, Switzerland.
Matteo Samuele PizzutoHumabs BioMed SA a Subsidiary of Vir Biotechnology Inc., Bellinzona, Switzerland.
University of Kansas · USVir Biotechnology (Switzerland) · CHUniversità della Svizzera italiana · CHOspedale regionale di Lugano · CHUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAntibodies, BacterialAntibodies, MonoclonalBacterial ProteinsBacterial VaccinesCampylobacterCampylobacter InfectionsDisease Models, AnimalDisease ResistanceFemaleGastroenteritisHumansImmunoglobulin AImmunotherapyIntestinal MucosaMiceAntibodies, BacterialAntibodies, MonoclonalBacterial ProteinsBacterial VaccinesFlaD protein, BacteriaImmunoglobulin ACampylobacterflagellar-capping proteinFliDmonoclonal antibodiesprophylaxissecretory IgA

Identifiers

PMID32582158
PMCPMC7296071
OpenAlexW3035635613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.